Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement Briefs: Updates On Elective Surgery Billing, DME, Proton Therapy, And Quality Improvement

This article was originally published in The Gray Sheet

Executive Summary

OIG finds savings for CMS in billing practices for canceled elective surgeries. CMS issues guidance on DME for dual eligibles. More reimbursement news.

You may also be interested in...



Preventable Hospital Events Moving In Right Direction, CMS Says

The volume of hospital-acquired conditions, including some device-related infections, has dropped in the past five years, according to an interim report released by the Centers for Medicare & Medicaid Services.

Reimbursement In Brief

Round two DMEPOS competitive bidding launched July 1 despite efforts by durable medical equipment makers and suppliers to delay it. OIG reports to CMS on continuous positive airway pressure supplies and therapeutic shoes. More reimbursement news.

Device Makers Seek Clarity On CMS' Plans For Coverage With Evidence Development

Many stakeholders want CMS to restrict conditional coverage to national determinations and prevent local Medicare carriers from imposing their own CED policies.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032339

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel